Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VA-REACH: Hydroxychloroquine vs Azithromycin in COVID-19
NCT04363203Phase 3Suspended
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19). Started Apr 2020; status: suspended.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04363203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363203.